Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer recognition
Customer-specific caching
Individual prices
PayPal payments
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Statistics & Tracking
Affiliate program
Google Tag Manager
Track device being used
Seraseq® Carrier Screening DNA Mix
Seraseq® Carrier Screening DNA Mix
#0730-0569 Seraseq Carrier Screening DNA Mix is a reference material intended for use in the development, validation, and evaluation of routine performance of Next Generation Sequencing (NGS) carrier screening assays (and other molecular assays) that identify inherited (germline) variants in genes associated with monogenic diseases.- Order number: 0730-0569
Seraseq Carrier Screening DNA Mix is a reference material intended for use in the development,... more
Seraseq Carrier Screening DNA Mix is a reference material intended for use in the development, validation, and evaluation of routine performance of Next Generation Sequencing (NGS) carrier screening assays (and other molecular assays) that identify inherited (germline) variants in genes associated with monogenic diseases. Seraseq Carrier Screening DNA Mix is a mixture of synthetic DNA constructs and genomic DNA extracted from the human cell line GM24385. It contains 54 clinically important SNVs, deletions and duplications occurring in inherited hemoglobinopathies, deafness, heart disease, immunodeficiency, neuromuscular and treatable metabolic disorders. The product is formulated to simulate a heterozygous state for each mutation at a 50% variant allele frequency (VAF) confirmed by droplet digital PCR and measured by NGS.
For additional information about the product, please visit the manufacturer's website.
PROPERTIES
storage temperature: | -20 °C |
shipping method: | dry ice |
regulatory status: | RUO |
Top-Seller
Top-Seller
Top-Seller
Tipp
Top-Seller
Top-Seller
Top-Seller
Viewed